Molecular mechanism of PPARα action and its impact on lipid metabolism …

Articles citing Molecular mechanism of PPARα action and its impact on lipid metabolism …

Title / Author	Year
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5	2016
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond U Beuers, M Trauner, P Jansen, R Poupon Journal of hepatology 62 (1), S25-S37	2015
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD B Gross, M Pawlak, P Lefebvre, B Staels Nature Reviews Endocrinology 13 (1), 36	2017
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD A Montagner, A Polizzi, E Fouché, S Ducheix, Y Lippi, F Lasserre, ... Gut 65 (7), 1202-1214	2016
Type 2 immunity in tissue repair and fibrosis RL Gieseck III, MS Wilson, TA Wynn Nature Reviews Immunology 18 (1), 62	2018
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases VT Samuel, GI Shulman Cell metabolism 27 (1), 22-41	2018
Pathophysiology and mechanisms of nonalcoholic fatty liver disease JT Haas, S Francque, B Staels Annual review of physiology 78, 181-205	2016
Recent insights on the role of cholesterol in non-alcoholic fatty liver disease G Arguello, E Balboa, M Arrese, S Zanlungo Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (9 …	2015
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease DH Ipsen, J Lykkesfeldt, P Tveden-Nyborg Cellular and molecular life sciences 75 (18), 3313-3327	2018
Nuclear receptors and nonalcoholic fatty liver disease MC Cave, HB Clair, JE Hardesty, KC Falkner, W Feng, BJ Clark, J Sidey, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1859 (9 …	2016
Regulation of ketone body metabolism and the role of PPARα M Grabacka, M Pierzchalska, M Dean, K Reiss International journal of molecular sciences 17 (12), 2093	2016
The selective SGLT2 inhibitor ipragliflozin has a therapeutic effect on nonalcoholic steatohepatitis in mice Y Honda, K Imajo, T Kato, T Kessoku, Y Ogawa, W Tomeno, S Kato, ... PLoS One 11 (1), e0146337	2016
An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans A Mardinoglu, H Wu, E Bjornson, C Zhang, A Hakkarainen, SM Räsänen, ... Cell metabolism 27 (3), 559-571. e5	2018
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis S Bala, T Csak, B Saha, J Zatsiorsky, K Kodys, D Catalano, ... Journal of hepatology 64 (6), 1378-1387	2016
Insights into the role and interdependence of oxidative stress and inflammation in liver diseases S Li, M Hong, HY Tan, N Wang, Y Feng Oxidative Medicine and Cellular Longevity 2016	2016
Therapeutic mechanisms of glucocorticoids J Vandewalle, A Luypaert, K De Bosscher, C Libert Trends in Endocrinology & Metabolism 29 (1), 42-54	2018
Pharmacological management of nonalcoholic fatty liver disease D Barb, P Portillo-Sanchez, K Cusi Metabolism 65 (8), 1183-1195	2016
Distinct but complementary contributions of PPAR isotypes to energy homeostasis V Dubois, J Eeckhoute, P Lefebvre, B Staels The Journal of clinical investigation 127 (4), 1202-1214	2017
PPARs and nonalcoholic fatty liver disease KHH Liss, BN Finck Biochimie 136, 65-74	2017
Blueberry as a source of bioactive compounds for the treatment of obesity, type 2 diabetes and chronic inflammation M Shi, H Loftus, AJ McAinch, XQ Su Journal of Functional Foods 30, 16-29	2017

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.